Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
106.94
+0.45 (0.42%)
Nov 5, 2024, 1:21 PM EST - Market open
Vaxcyte Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 13,231 | 5,976 | 3,787 | 1,256 | 1,354 | - | |
Market Cap Growth | 75.55% | 57.79% | 201.58% | -7.24% | - | - | |
Enterprise Value | 11,745 | 4,724 | 3,445 | 978 | 957 | - | |
Last Close Price | 106.49 | 62.80 | 47.95 | 23.79 | 26.57 | - | |
PE Ratio | - | -15.17 | -13.92 | -12.34 | -8.80 | - | |
PB Ratio | 5.93 | 4.82 | 3.97 | 4.42 | 3.91 | - | |
P/FCF Ratio | -14.11 | -16.39 | -21.46 | -9.81 | -28.33 | - | |
P/OCF Ratio | -17.60 | -20.13 | -22.20 | -10.34 | -29.03 | - | |
EV/EBITDA Ratio | -11.79 | -10.16 | -15.00 | -9.60 | -10.85 | - | |
EV/EBIT Ratio | -11.71 | -10.09 | -14.83 | -9.44 | -10.68 | - | |
EV/FCF Ratio | -11.60 | -12.95 | -19.52 | -7.65 | -20.02 | - | |
Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.06 | - | 0.00 | |
Debt / FCF Ratio | -0.04 | -0.08 | -0.10 | -0.13 | - | 0.00 | |
Quick Ratio | 17.75 | 7.46 | 23.08 | 8.61 | 8.25 | 5.35 | |
Current Ratio | 17.88 | 7.54 | 23.26 | 8.93 | 8.30 | 5.58 | |
Return on Equity (ROE) | -29.08% | -36.67% | -36.11% | -31.78% | -44.58% | -87.49% | |
Return on Assets (ROA) | -20.10% | -24.23% | -21.82% | -18.07% | -24.42% | -49.59% | |
Return on Capital (ROIC) | -20.85% | -26.10% | -22.82% | -20.04% | -27.97% | -57.01% | |
Earnings Yield | -3.77% | -6.73% | -5.90% | -7.97% | -6.59% | - | |
FCF Yield | -4.42% | -6.10% | -4.66% | -10.19% | -3.53% | - | |
Buyback Yield / Dilution | -33.12% | -49.75% | -24.95% | -75.73% | -678.53% | -4.55% | |
Total Shareholder Return | -33.12% | -49.75% | -24.95% | -75.73% | -678.53% | -4.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.